D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 68 Citations 20,033 215 World Ranking 1323 National Ranking 587

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Acquired immunodeficiency syndrome
  • Disease

His primary areas of study are Internal medicine, Immunology, Acquired immunodeficiency syndrome, Cohort study and Cohort. David Rimland combines subjects such as Coinfection, Surgery and Hepatitis C virus with his study of Internal medicine. His research integrates issues of Young adult and Case-control study in his study of Immunology.

The concepts of his Acquired immunodeficiency syndrome study are interwoven with issues in Epidemiology, Gerontology, Confidence interval, Essential hypertension and Depression. His Cohort study research includes themes of Prospective cohort study, Proportional hazards model and Myocardial infarction. His studies deal with areas such as Psychological intervention, Incidence, Medical record, Alcohol abuse and Hazard ratio as well as Cohort.

His most cited work include:

  • Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study (2421 citations)
  • HIV Infection and the Risk of Acute Myocardial Infarction (785 citations)
  • USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus (404 citations)

What are the main themes of his work throughout his whole career to date?

His scientific interests lie mostly in Internal medicine, Cohort study, Immunology, Acquired immunodeficiency syndrome and Cohort. His research is interdisciplinary, bridging the disciplines of Surgery and Internal medicine. The various areas that David Rimland examines in his Cohort study study include Gerontology, Confidence interval, Proportional hazards model, Prospective cohort study and Comorbidity.

In his research on the topic of Immunology, Opportunistic infection is strongly related with Pneumonia. Within one scientific family, David Rimland focuses on topics pertaining to Viral disease under Acquired immunodeficiency syndrome, and may sometimes address concerns connected to Immunopathology. David Rimland works mostly in the field of Cohort, limiting it down to topics relating to Incidence and, in certain cases, Pediatrics.

He most often published in these fields:

  • Internal medicine (72.92%)
  • Cohort study (38.54%)
  • Immunology (36.81%)

What were the highlights of his more recent work (between 2014-2020)?

  • Internal medicine (72.92%)
  • Cohort study (38.54%)
  • Cohort (21.18%)

In recent papers he was focusing on the following fields of study:

David Rimland mainly investigates Internal medicine, Cohort study, Cohort, Immunology and Veterans Affairs. His Cohort study research includes elements of Odds ratio, Physical therapy, Incidence, Gerontology and Prospective cohort study. His Prospective cohort study research focuses on subjects like Acquired immunodeficiency syndrome, which are linked to Cancer and Absolute risk reduction.

David Rimland has included themes like Viremia, Viral load, Cancer registry, Disease and Seroconversion in his Cohort study. His study in Immunology is interdisciplinary in nature, drawing from both Biomarker, Alanine transaminase and Pneumonia. His Veterans Affairs study incorporates themes from Vitamin D and neurology, vitamin D deficiency and Risk of mortality.

Between 2014 and 2020, his most popular works were:

  • Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study (2421 citations)
  • Comparison of Risk and Age at Diagnosis of Myocardial Infarction, End-Stage Renal Disease, and Non-AIDS-Defining Cancer in HIV-Infected Versus Uninfected Adults (165 citations)
  • HIV status and the risk of ischemic stroke among men. (117 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Acquired immunodeficiency syndrome
  • Disease

Internal medicine, Cohort study, Cohort, Hazard ratio and Immunology are his primary areas of study. His research brings together the fields of Viral load and Internal medicine. His work deals with themes such as Incidence, Myocardial infarction, Hiv infected, Physical therapy and Risk factor, which intersect with Cohort study.

His Cohort research incorporates elements of Rate ratio, Hepatitis C and Seroconversion. His work deals with themes such as Biomarker and Absolute risk reduction, which intersect with Immunology. His work carried out in the field of Acquired immunodeficiency syndrome brings together such families of science as Circulating MicroRNA and Case-control study.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study

Daniel D. Murray;Kazuo Suzuki;Matthew Law;Jonel Trebicka.
PLOS ONE (2015)

4699 Citations

HIV Infection and the Risk of Acute Myocardial Infarction

Matthew S. Freiberg;Chung Chou H Chang;Lewis H. Kuller;Melissa Skanderson.
JAMA Internal Medicine (2013)

1260 Citations

USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus

David Lanier;Neil Schram;Ellen Cooper;Kenneth A. Freedberg.
Clinical Infectious Diseases (1995)

630 Citations

The Changing Epidemiology of Cryptococcosis: An Update from Population-Based Active Surveillance in 2 Large Metropolitan Areas, 1992–2000

Sara A. Mirza;Maureen Phelan;David Rimland;David Rimland;Edward A. Graviss.
Clinical Infectious Diseases (2003)

560 Citations

RAPID DEVELOPMENT OF CIPROFLOXACIN RESISTANCE IN METHICILLIN-SUSCEPTIBLE AND -RESISTANT STAPHYLOCOCCUS AUREUS

H M Blumberg;D Rimland;D J Carroll;P Terry.
The Journal of Infectious Diseases (1991)

405 Citations

HIV infection and risk for incident pulmonary diseases in the combination antiretroviral therapy era

Kristina Crothers;Laurence Huang;Joseph L. Goulet;Matthew Bidwell Goetz.
American Journal of Respiratory and Critical Care Medicine (2011)

399 Citations

Do Patterns of Comorbidity Vary by HIV Status, Age, and HIV Severity?

Joseph L. Goulet;Shawn L. Fultz;David Rimland;Adeel Butt.
Clinical Infectious Diseases (2007)

375 Citations

Hepatitis C in the HIV (Human Immunodeficiency Virus) Atlanta V.A. (Veterans Affairs Medical Center) Cohort Study (HAVACS): The Effect of Coinfection on Survival

C. T. Staples;D. Rimland;D. Dudas.
Clinical Infectious Diseases (1999)

349 Citations

Outbreak of Clostridium difficile Infection in a Long-Term Care Facility: Association with Gatifloxacin Use

Robert Gaynes;Robert Gaynes;David Rimland;David Rimland;Edna Killum;H. Ken Lowery.
Clinical Infectious Diseases (2004)

337 Citations

Veterans Aging Cohort Study (VACS): Overview and description.

Amy C. Justice;Elizabeth Dombrowski;Joseph Conigliaro;Shawn L. Fultz.
Medical Care (2006)

312 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing David Rimland

Amy C. Justice

Amy C. Justice

Yale University

Publications: 237

Adeel A. Butt

Adeel A. Butt

Hamad Medical Corporation

Publications: 74

Laurence Huang

Laurence Huang

University of California, San Francisco

Publications: 71

Phyllis C. Tien

Phyllis C. Tien

University of California, San Francisco

Publications: 69

David A. Fiellin

David A. Fiellin

Yale University

Publications: 69

Steven K. Grinspoon

Steven K. Grinspoon

Harvard University

Publications: 60

Maria C. Rodriguez-Barradas

Maria C. Rodriguez-Barradas

Baylor College of Medicine

Publications: 55

Richard D. Moore

Richard D. Moore

Johns Hopkins University

Publications: 51

Peter Reiss

Peter Reiss

University of Amsterdam

Publications: 50

Jens D. Lundgren

Jens D. Lundgren

Rigshospitalet

Publications: 46

Carl Grunfeld

Carl Grunfeld

University of California, San Francisco

Publications: 43

Michael J. Silverberg

Michael J. Silverberg

Kaiser Permanente

Publications: 43

Robert F. Miller

Robert F. Miller

University College London

Publications: 42

Grace A. McComsey

Grace A. McComsey

Case Western Reserve University

Publications: 42

Matthew Bidwell Goetz

Matthew Bidwell Goetz

University of California, Los Angeles

Publications: 41

Michael S. Saag

Michael S. Saag

University of Alabama at Birmingham

Publications: 38

Trending Scientists

Frank Vetere

Frank Vetere

University of Melbourne

John Chiasson

John Chiasson

Boise State University

Rick A. Hamilton

Rick A. Hamilton

Optum (United States)

Todd M. Alam

Todd M. Alam

Sandia National Laboratories

Stephen Hanessian

Stephen Hanessian

University of Montreal

Elizabeth A. Dinsdale

Elizabeth A. Dinsdale

San Diego State University

Giles E. Hardingham

Giles E. Hardingham

University of Edinburgh

Sven Fuchs

Sven Fuchs

University of Natural Resources and Life Sciences

Chikao Morimoto

Chikao Morimoto

Juntendo University

Karen S. Rook

Karen S. Rook

University of California, Irvine

Martin Whiteman

Martin Whiteman

Columbia University

Akira Miyauchi

Akira Miyauchi

Tokai University

Janet E. Olson

Janet E. Olson

Mayo Clinic

Carmine Zoccali

Carmine Zoccali

National Academies of Sciences, Engineering, and Medicine

Eric A. F. Simões

Eric A. F. Simões

University of Colorado Denver

Kwame McKenzie

Kwame McKenzie

University of Toronto

Something went wrong. Please try again later.